HC Wainwright & Co.:重申Vivani Medical评级

证券之星
13 Mar

HC Wainwright&Co.:重申Vivani Medical(VANI.US)评级,由买入调整至买入评级,目标价由4.00美元调整至4.00美元。Vivani Medical(VANI.US)公司简介:Vivani Medical Inc是一家处于临床前阶段的生物制药公司。该公司利用其专有的NanoPortal技术开发微型皮下植入物,以实现广泛范围药物的长期、近恒定速率输送,用于治疗慢性...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10